×
QQQ   299.33 (+2.77%)
AAPL   143.78 (+2.32%)
MSFT   265.90 (+1.29%)
FB   191.63 (+4.24%)
GOOGL   2,155.85 (+1.88%)
AMZN   2,221.55 (+4.03%)
TSLA   707.73 (+7.43%)
NVDA   178.51 (+5.16%)
BABA   94.48 (+14.79%)
NIO   16.03 (+9.49%)
AMD   98.75 (+6.58%)
CGC   5.55 (+10.34%)
MU   70.60 (+4.02%)
T   21.32 (+0.09%)
GE   77.01 (+3.33%)
F   13.12 (+3.23%)
DIS   105.61 (+2.28%)
AMC   12.23 (+2.95%)
PFE   53.99 (+0.52%)
PYPL   80.42 (+0.37%)
NFLX   191.40 (+1.90%)
QQQ   299.33 (+2.77%)
AAPL   143.78 (+2.32%)
MSFT   265.90 (+1.29%)
FB   191.63 (+4.24%)
GOOGL   2,155.85 (+1.88%)
AMZN   2,221.55 (+4.03%)
TSLA   707.73 (+7.43%)
NVDA   178.51 (+5.16%)
BABA   94.48 (+14.79%)
NIO   16.03 (+9.49%)
AMD   98.75 (+6.58%)
CGC   5.55 (+10.34%)
MU   70.60 (+4.02%)
T   21.32 (+0.09%)
GE   77.01 (+3.33%)
F   13.12 (+3.23%)
DIS   105.61 (+2.28%)
AMC   12.23 (+2.95%)
PFE   53.99 (+0.52%)
PYPL   80.42 (+0.37%)
NFLX   191.40 (+1.90%)
QQQ   299.33 (+2.77%)
AAPL   143.78 (+2.32%)
MSFT   265.90 (+1.29%)
FB   191.63 (+4.24%)
GOOGL   2,155.85 (+1.88%)
AMZN   2,221.55 (+4.03%)
TSLA   707.73 (+7.43%)
NVDA   178.51 (+5.16%)
BABA   94.48 (+14.79%)
NIO   16.03 (+9.49%)
AMD   98.75 (+6.58%)
CGC   5.55 (+10.34%)
MU   70.60 (+4.02%)
T   21.32 (+0.09%)
GE   77.01 (+3.33%)
F   13.12 (+3.23%)
DIS   105.61 (+2.28%)
AMC   12.23 (+2.95%)
PFE   53.99 (+0.52%)
PYPL   80.42 (+0.37%)
NFLX   191.40 (+1.90%)
QQQ   299.33 (+2.77%)
AAPL   143.78 (+2.32%)
MSFT   265.90 (+1.29%)
FB   191.63 (+4.24%)
GOOGL   2,155.85 (+1.88%)
AMZN   2,221.55 (+4.03%)
TSLA   707.73 (+7.43%)
NVDA   178.51 (+5.16%)
BABA   94.48 (+14.79%)
NIO   16.03 (+9.49%)
AMD   98.75 (+6.58%)
CGC   5.55 (+10.34%)
MU   70.60 (+4.02%)
T   21.32 (+0.09%)
GE   77.01 (+3.33%)
F   13.12 (+3.23%)
DIS   105.61 (+2.28%)
AMC   12.23 (+2.95%)
PFE   53.99 (+0.52%)
PYPL   80.42 (+0.37%)
NFLX   191.40 (+1.90%)
NASDAQ:STRO

Sutro Biopharma SEC Filings & 10K Form

$4.38
-0.06 (-1.35%)
(As of 05/26/2022 04:00 PM ET)
Add
Compare
Today's Range
$4.35
$4.56
50-Day Range
$4.38
$9.70
52-Week Range
$4.32
$23.70
Volume
591,503 shs
Average Volume
565,835 shs
Market Capitalization
$205.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.11

Sutro Biopharma (NASDAQ:STRO) SEC Filings

DateFilerForm TypeView
05/19/2022
11:15 PM
Sutro Biopharma (Filer)
Form EFFECT
05/09/2022
3:31 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2022
6:58 PM
Sutro Biopharma (Filer)
Form DEFA14A
04/22/2022
6:55 PM
Sutro Biopharma (Filer)
Form DEF 14A
04/20/2022
6:00 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2022
6:19 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2021
6:01 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2021
4:29 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2021
4:08 PM
Sutro Biopharma (Issuer)
Wigginton Jon Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
4:07 PM
Sharp Shalini (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
4:06 PM
Petree Daniel H (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
4:05 PM
PANEK JAMES P (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
4:04 PM
MATSUI CONNIE (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
4:04 PM
Lobacki Joseph M (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
4:02 PM
Freund John Gordon (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2021
6:00 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2021
4:00 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2021
6:00 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2021
4:38 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2021
6:00 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2021
4:28 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
04/02/2021
3:59 PM
Sutro Biopharma (Filer)
Form S-3ASR
03/18/2021
6:00 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2021
4:20 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
4:20 PM
MOLINA ARTURO MD (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
4:19 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
4:18 PM
FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
4:17 PM
Shabbir Anik (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
4:16 PM
ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
3:30 PM
CITADEL ADVISORS LLC (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
02/12/2021
3:25 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
02/01/2021
4:56 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
4:55 PM
MOLINA ARTURO MD (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
4:55 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
4:54 PM
FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
4:53 PM
Shabbir Anik (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
4:48 PM
ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2021
4:05 PM
Petree Daniel H (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2021
4:04 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
4:21 PM
FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2021
5:10 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2020
4:00 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2020
5:40 PM
Freund John Gordon (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
3:38 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2020
3:02 PM
Sutro Biopharma (Filer)
Form 424B5
12/08/2020
7:30 PM
Sutro Biopharma (Filer)
Form S-3MEF
12/07/2020
3:10 PM
Sutro Biopharma (Filer)
Form 424B5
12/07/2020
2:45 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2020
4:10 PM
Sutro Biopharma (Issuer)
Wigginton Jon Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2020
4:06 PM
Sutro Biopharma (Issuer)
Wigginton Jon Marc (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/01/2020
6:09 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2020
4:14 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2020
3:59 PM
Freund John Gordon (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2020
4:08 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2020
6:05 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2020
8:31 PM
Sutro Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/06/2020
3:54 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2020
4:57 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2020
4:56 PM
MOLINA ARTURO MD (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2020
4:55 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2020
4:54 PM
FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2020
4:53 PM
Shabbir Anik (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2020
4:52 PM
ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2020
3:56 PM
Freund John Gordon (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2020
4:15 PM
Freund John Gordon (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2020
4:23 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2020
3:06 PM
EcoR1 Capital, LLC (Filed by)
Sutro Biopharma (Subject)
Form SC 13G
08/27/2020
4:04 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2020
4:18 PM
Freund John Gordon (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
6:03 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2020
4:08 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:21 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2020
4:46 PM
PANEK JAMES P (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:36 PM
Sharp Shalini (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:35 PM
Petree Daniel H (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:28 PM
MATSUI CONNIE (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:27 PM
Lobacki Joseph M (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:26 PM
Freund John Gordon (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:25 PM
Dybbs Michael (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:43 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2020
5:38 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
4:22 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Sutro Biopharma (Subject)
Form SC 13G
05/14/2020
4:29 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
4:27 PM
MOLINA ARTURO MD (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
4:26 PM
FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
4:14 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
3:27 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
3:12 PM
Sutro Biopharma (Filer)
Form 424B5
04/27/2020
7:24 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2020
7:00 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2020
4:32 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2020
5:04 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2020
4:34 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
3:17 PM
Lilly Ventures Fund I LLC (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
02/12/2020
1:28 PM
Skyline Venture Partners V LP (Filed by)
Sutro Biopharma (Subject)
Form SC 13G
02/10/2020
4:26 PM
CELGENE CORP /DE/ (Filed by)
Sutro Biopharma (Subject)
Form SC 13G
01/31/2020
4:20 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2020
4:18 PM
MOLINA ARTURO MD (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2020
4:17 PM
Hallam Trevor (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2020
4:15 PM
Shabbir Anik (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 5/26/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.